BNTX — BioNTech SE
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1776985 ·
Last close
$99.08
Market Cap
$24.89B
52W High
$124.00
52W Low
$79.52
ADV30
1,447,173
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 105,600,000 | 8,600,000 | -938,700,000 | -820,800,000 | 20,342,600,000 | 9,741,000,000 | 2,585,100,000 |
| Mar 2026 | 118,100,000 | 46,700,000 | -677,500,000 | -531,900,000 | 21,074,100,000 | 9,939,400,000 | 2,376,300,000 |
| Dec 2025 | 907,400,000 | 574,100,000 | -280,500,000 | -305,000,000 | 21,988,600,000 | 7,675,400,000 | 2,764,400,000 |
| Sep 2025 | 1,518,900,000 | 1,370,600,000 | 653,900,000 | -28,700,000 | 21,341,100,000 | 10,092,900,000 | 2,863,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$679,700,000
Investing CF
$-1,100,400,000
Financing CF
$-107,900,000
CapEx
$-235,000,000
Dividends Paid
—
Buybacks
$-129,200,000
EPS Diluted TTM
$-6.71
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$16,609,200,000
Inventory
$100,600,000
Receivables
$245,200,000
ST Investments
$5,037,800,000
EBIT TTM
$-1,441,800,000
Pretax Income TTM
$-1,629,500,000
Interest Exp TTM
$14,900,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,649,999,872
EBITDA
$-1,380,800,000
Free Cash Flow
$-249,562,496
Enterprise Value
$11,151,198,208
Total Cash
$13,463,900,160
Total Debt
$316,100,000
Shares Out
251,204,366
Trailing EPS
$-7.81
Book Value
$82.23
ROE
-9.3%
ROA
-5.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,869,900,000 | -640,700,000 | -1,136,100,000 | 21,988,600,000 | 2,764,400,000 | 19,224,200,000 | 456,000,000 |
| Dec 2024 | 2,751,100,000 | -709,400,000 | -665,300,000 | 22,529,700,000 | 3,118,600,000 | 19,411,100,000 | 207,700,000 |
| Dec 2023 | 3,819,000,000 | 875,600,000 | 930,300,000 | 23,006,300,000 | 2,760,400,000 | 20,245,900,000 | 5,371,400,000 |
| Dec 2022 | 17,310,600,000 | 12,303,800,000 | 9,434,400,000 | 23,279,100,000 | 3,223,500,000 | 20,055,600,000 | 13,577,400,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-5.69
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $100.00 · spot: $99.08 · call volume: 1,381 · put volume: 449
Expected Move to 2026-10-16:
±$8.21
(8.29%) —
implied range
$90.87 –
$107.29
· ATM straddle on $100.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIIB | BIOGEN INC. | $33.79B | $228.69 | — |
| EXEL | EXELIXIS, INC. | $14.46B | $58.37 | — |
| RVMD | Revolution Medicines, Inc. | $43.24B | $201.74 | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | $14.28B | $140.44 | — |
| HALO | HALOZYME THERAPEUTICS, INC. | $12.81B | $112.89 | — |
News headlines (Yahoo Finance, 1h cache)
How New Lung Cancer Data And Updated COVID Shot At BioNTech (BNTX) Has Changed Its Investment Story
2026-09-27 01:10 · Yahoo
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
2026-09-24 20:27 · Yahoo
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines
2026-09-23 21:30 · Yahoo
Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?
2026-09-22 14:51 · Yahoo
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
2026-09-21 18:38 · Yahoo
Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher
2026-09-21 15:45 · Yahoo
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
2026-09-17 13:50 · Yahoo
Is BioNTech (BNTX) Too Pricey for Its Current Sales Base?
2026-09-16 22:13 · Yahoo
BioNTech (BNTX) Posts Strong Lung Cancer Data, Is It A Bargain?
2026-09-16 19:08 · Yahoo
BioNTech’s Lung Cancer Drug Shows Signs of a Major Breakthrough
2026-09-15 14:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.